[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

CN1097601A - The medicine and the preparation technology thereof of treatment tinea pedis - Google Patents

The medicine and the preparation technology thereof of treatment tinea pedis Download PDF

Info

Publication number
CN1097601A
CN1097601A CN93108743A CN93108743A CN1097601A CN 1097601 A CN1097601 A CN 1097601A CN 93108743 A CN93108743 A CN 93108743A CN 93108743 A CN93108743 A CN 93108743A CN 1097601 A CN1097601 A CN 1097601A
Authority
CN
China
Prior art keywords
gram
medicine
acid
tinea pedis
propolis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN93108743A
Other languages
Chinese (zh)
Inventor
李乐选
谢人明
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN93108743A priority Critical patent/CN1097601A/en
Publication of CN1097601A publication Critical patent/CN1097601A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

A kind of medicine and preparation technology thereof who treats tinea pedis is main component with propolis, Lac regis apis, Venenum apis, is equipped with compositions such as ketoconazole, Alumen, salicylic acid again.This medicine has safety non-toxic, nonirritant, inhibition tinea bacteria growing, anti-inflammatory anti-itch analgesia, promotes the histiocyte regeneration function, dermatophytes is had extremely strong killing action.Its preparation technology is simple, cheap, easy to use, formulation rate is little, is suitable for all tinea pedis patients and uses, and special efficacy is arranged.

Description

The medicine and the preparation technology thereof of treatment tinea pedis
The present invention relates to a kind of medicine and preparation technology thereof who treats tinea pedis, belong to medicine and make the field.
Tinea pedis (being commonly called as beriberi, tinea pedis) is that crowd's sickness rate in a kind of sickness rate very high multiple cutaneous disease, especially underground labour, the soldier of army, athlete, ironworker, southern vast town and country, subtropical zone, the torrid zone is more concentrated and the residence is high.Add the cross infection of common plunge bath, public slippers etc., cause the people of 60-70% to suffer from this disease.Pruritus is scratched water blood Tianjin stream behind the skin unbearably if then moist erosion in affected part of bacterial infection, toe edema, the dense blood and slime of outflow and frowziness are arranged between ill initial stage toe.This is sick brings very big influence for life, work and study of patient, must hospitalization when serious, but do not have special-effect.China's traditional medicine thinks that these cause of disease taste two form or occupy for a long time wetland or water slurry dipping through damp invasion of lower energizer, and noxious dampness is contaminated due to the skin.Doctor trained in Western medicine is then thought to be caused by fungal infection.Drug therapys such as at present clinical " JIAOXIAN YICIJING " " zinci undecylenatis compositum " commonly used, " Compound Flavescent Sophora and Salicylic Acid Powder ", " daktarin ", " beriberi paste ", " Cortex Pseudolaricis tincture ", though can be temporarily antipruritic, slow down symptom, large usage quantity also has recurrence in a short time.Some medicine is bigger as zests such as " Cortex Pseudolaricis tincture ", " JIAOXIAN YICIJING " in addition, and pain is brought very big misery to the patient unbearably during use.Also do not see this sick specific medicament of treatment up to now.
Purpose of the present invention is exactly that a kind of consumption is less, price is lower and provide at the deficiency in the above-mentioned background technology, can suppress fungal infection, the medicine and the preparation technology thereof of anti-inflammation, antipruritic deodorant treatment tinea pedis.
The technical solution that realizes the object of the invention is such: contain propolis 2.5-5.0 gram, Lac regis apis 0.8-3.0 gram, ketoconazole 0.8-3.0 gram, benzoic acid 3.0-7.0 gram, boric acid 10.0-19.0 gram, Alumen 10.0-19.0 gram, tannic acid 10.0-19.0 gram, sodium chloride 15.0-27.0 gram, salicylic acid 15.0-27.0 gram, Venenum apis 0.001-0.005 gram in the medicine of the present invention.Its preparation technology be by consumption with propolis in-8 ℃-0 ℃ temperature after freezing 5-16 hour levigation cross 120 mesh sieves, add ketoconazole, benzoic acid, boric acid, Alumen, tannic acid, sodium chloride, the mixing of salicylic acid levigation more according to quantity, add the even encapsulation of lyophilizing royal jelly and Venenum apis fine powder grinding again and get final product.
Below in conjunction with embodiment the present invention is done an explanation.
At first with the propolis of 2.5-5.0 gram under-8 ℃-0 ℃ temperature freezing 7-12 hour, grind and cross 120 mesh sieves after making it crisp firmly, again the salicylic acid fine powder of the sodium chloride of the tannic acid of the Alumen of the boric acid of the benzoic acid of the ketoconazole of 0.9-2.8 gram, 3.2-6.7 gram, 10.5-18.0 gram, 10.5-18.0 gram, 10.5-18.0 gram, 15.2-25.0 gram, 15.5-25.0 gram is added and mix, add in above mixed powder again that lyophilizing royal jelly 0.8-3.0 gram and Venenum apis 0.001-0.005 restrain, encapsulate behind the fine powder mix homogeneously and get final product.
The effect of contained each composition in this medicine:
Propolis: contain flavone, flavonol, flavanone, Quercetin, cinnamic acid, cinnamyl alcohol, vanillin, caffeic acid and 5-hydroxyl 2-7-dimethoxy flavone, 5-7-dihydroxy-2,4-dimethoxy flavone and ferulic acid etc.Propolis has antibacterial, fungus, virus and suppresses and killing action, can also antiinflammatory, analgesia, antipruritic, promote tissue regeneration.
Lac regis apis: contain 10-hydroxyl decanoic acid (having another name called Royal Jelly acid) and active polypeptide etc.Lac regis apis has the growth promoter of promotion and rejuvenation effect, and old and feeble and impaired histiocyte is replaced by new cell, makes cell function normalization.
Benzoic acid, boric acid, salicylic acid, tannic acid: anti-tinea bacterium is all arranged, suppress the effect of its growth, but and horny layer softening confluent monolayer cells.
Sodium chloride: can anticorrosion antiinflammatory.
Alumen: have astringent therapy, bacteriostasis.
Ketoconazole: can suppress the tinea bacteria growing, treatment dermatophytes sexuality is dyed.
Venenum apis: can make local anesthesia, and can increase antibody.
Every experimental result that medicine of the present invention carries out through the Traditional Chinese Medicine Research Institute, Shanxi Province is as follows:
One, acute toxicity testing: stomach is irritated by 0.2 milliliter/20 grams (be equivalent to be grown up dosage 100 times) in each 10 fasting (can't help water) of ICR strain white mice male and female of getting 18-22 gram back of spending the night, and observes all no abnormal reaction in 7 days.Through all no abnormal discoveries of important organ such as the anatomic observation heart, liver, spleen, lung, kidneys.
Two, pharmacodynamic experiment:
1, experimental technique stimulates and allergic experiment with the Mus skin of back routinely, and this medicine does not cause skin erythema, edema, does not cause skin erosion.Carry out also non-toxic reaction of skin acute toxicity testing with rabbit.
2, the damaged skin after the wound (operation cut) is had no stimulation, and the effect of rapid hemostasis, promotion skin healing is arranged.
3, adhere to this medicine and stick on the culture dish of the various antibacterials of inoculation and cultivated 24 hours with soaking the scraps of paper, conclusion is can suppress from the effect of the isolated white epidermis trichophyton of tinea pedis patient skin.
4, experimental results show that with white mice acetic acid twisting method this medicine has significant analgesic activity.
158 examples are observed in clinical practice altogether, and obvious effective rate is 98%, and recovery from illness rapidly after the medication does not have recurrence in 1 year.Show as antipruritic, pain relieving, only ooze out, the very fast healing of damaged skin, the disease of casting off a skin in the week takes a turn for the better, recovery from illness.Clean both feet before the patient sleeps, this drug powder is coated with touches in the affected part.The lighter's medication 1 gram, weight person's medication 2-4 gram can be fully recovered.
The present invention is Main Ingredients and Appearance owing to having adopted honeybee series of products such as propolis, royal jelly and bee venom, be equipped with again the medicines such as ketoconazole, alum, salicylic acid, have safety non-toxic, nonirritant, inhibition tinea bacteria growing, anticorrosion anti-inflammatory, deodorizing, relieving iching by astringing analgesia, promote the histocyte regeneration function, dermatophyte is had extremely strong killing action. This pharmaceutical preparation is simple, cheap, formulation rate is few, easy to use, be suitable for all tinea pedis disease patients effect, and special curative effect arranged.

Claims (3)

1, a kind of medicine for the treatment of tinea pedis, comprising benzoic acid, salicylic acid, the invention is characterized in and contain propolis 2.5-5.0 gram, Lac regis apis 0.8-3.0 gram, ketoconazole 0.8-3.0 gram, benzoic acid 3.0-7.0 gram, boric acid 10.0-19.0 gram, Alumen 10.0-19.0 gram, tannic acid 10.0-19.0 gram, sodium chloride 15.0-27.0 gram, salicylic acid 15.0-27.0 gram, Venenum apis 0.001-0.005 gram in this medicine.
2, medicine according to claim 1 is characterized in that described propolis is the lyophilizing propolis; Lac regis apis is a frozen dry roral jelly.
3, a kind of technology for preparing the medicine for the treatment of tinea pedis, comprise mixing, levigation operation, it is characterized in that propolis with 2.5-5.0 gram in-8 ℃-0 ℃ temperature after freezing 5-16 hour levigation cross 120 mesh sieves, add ketoconazole 0.8-3.0 gram, benzoic acid 3.0-7.0 gram, boric acid 10.0-19.0 gram, Alumen 10.0-19.0 gram, tannic acid 10.0-19.0 gram, sodium chloride 15.0-27.0 gram, salicylic acid 15.0-27.0 gram levigation again and mix, add frozen dry roral jelly 0.8-3.0 gram at last and Venenum apis 0.001-0.005 gram fine powder grinds even.
CN93108743A 1993-07-17 1993-07-17 The medicine and the preparation technology thereof of treatment tinea pedis Pending CN1097601A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN93108743A CN1097601A (en) 1993-07-17 1993-07-17 The medicine and the preparation technology thereof of treatment tinea pedis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN93108743A CN1097601A (en) 1993-07-17 1993-07-17 The medicine and the preparation technology thereof of treatment tinea pedis

Publications (1)

Publication Number Publication Date
CN1097601A true CN1097601A (en) 1995-01-25

Family

ID=4987280

Family Applications (1)

Application Number Title Priority Date Filing Date
CN93108743A Pending CN1097601A (en) 1993-07-17 1993-07-17 The medicine and the preparation technology thereof of treatment tinea pedis

Country Status (1)

Country Link
CN (1) CN1097601A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1088994C (en) * 1999-05-14 2002-08-14 乔顺朝 Medicinal composition for treating foot ringworm
CN101129409B (en) * 2007-08-30 2011-06-01 程贵昌 Antimycotic externally used drug
EP2863907A1 (en) * 2012-06-26 2015-04-29 Universitätsklinikum Freiburg Pharmaceutical composition having synergistic action of direct catalase inhibitors and modulators of no metabolism or of extracellular superoxide anion production which lead to catalase destruction
CN111450128A (en) * 2020-06-01 2020-07-28 王刚建 Medicine for treating beriberi

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1088994C (en) * 1999-05-14 2002-08-14 乔顺朝 Medicinal composition for treating foot ringworm
CN101129409B (en) * 2007-08-30 2011-06-01 程贵昌 Antimycotic externally used drug
EP2863907A1 (en) * 2012-06-26 2015-04-29 Universitätsklinikum Freiburg Pharmaceutical composition having synergistic action of direct catalase inhibitors and modulators of no metabolism or of extracellular superoxide anion production which lead to catalase destruction
CN111450128A (en) * 2020-06-01 2020-07-28 王刚建 Medicine for treating beriberi

Similar Documents

Publication Publication Date Title
KR20100016450A (en) External compositions for the skin
CN112245497A (en) Chinese medicinal preparation for sterilizing, diminishing inflammation and promoting wound healing and preparation method thereof
JPH08511283A (en) Product for skin regeneration and treatment, method for producing the same and use thereof
CN111297961A (en) Dong medicine for promoting wound healing
JP2009269904A (en) Herbal medicinal composition for curing external wound and bedsore and method of manufacturing medicine from the composition
US7270834B2 (en) Pharmaceutical composition comprising dimethylsulfoxide and ozone
CN1097601A (en) The medicine and the preparation technology thereof of treatment tinea pedis
CN100402074C (en) A Chinese medicinal ointment for promoting wound healing after anal fistula operation and preparation method thereof
CN103690903B (en) A kind of Chinese traditional compound medicine for the treatment of the injuries such as burn and scald decubital ulcer
CN101332286B (en) Traditional Chinese medicine composition for treating skin disease and preparation method thereof
CN108126109A (en) Wound burn bacteriostatic and its processing method
CN1072499C (en) External-use medicine for curing various chronic ulcers
CN1186068C (en) Externally applied Chinese medicine with functions of diminishing inflammation, promoting granulation, stopping itch and stopping pain and its prepn process
CN1274596A (en) Compound bee venom liniment and its preparation
CN107982300B (en) Spray and preparation method and application thereof
CN1167430C (en) Broad-spectrum antibacterial Huangru Ointment for treating deep burn
CN1062456C (en) Specific remedy for curing comedo and acne and its preparation method
CN1284494A (en) Bamboo parasitic fungus extract and its preparation and application
CN105920103A (en) External spray for treating dermatophytosis and preparation method thereof
CN1100527C (en) Skin health-care lotion
CN115463077A (en) Firming and repairing essence and preparation method thereof
RU2614392C1 (en) Combination for acne treatment and method of its application
CN116870081A (en) Composition for preventing and treating radiotherapy and chemotherapy related skin mucosa injury and application thereof
CN1064534C (en) Medicine for skin disease
CN112741863A (en) Medicine for treating skin wound and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication